Adenoviral Vaccines

Adenoviral Vaccines

Adenovirus-based vaccines have been shown to induce the highest B- and CD8+ T-cell responses against a variety of immunogens derived from a number of infectious agents (e.g., viruses, parasites, or bacterial pathogens) and tumor cells, including tumor-associated antigens (TAAs) in experimental animals and in human clinical trials. Ad-vectors can be propagated to high yields in well-defined production systems that are readily amenable to pharmaceutical scale production of clinical grade compositions.

Takis has generated Ad-vectors based cancer vaccines able to break immune tolerance against TAAs.


adenoviral vaccines



Follow Us on Linkedin

Lorem ipsum dolor sit amet, consetetur sadipscing sed diam nonumy eirmod tempor invidunt

Visit our page